{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:38:09Z","timestamp":1787621889186,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pancreatic medullary carcinoma (PMC) is a rare pancreatic tumor, usually showing the presence of microsatellite instability, mostly MLH1 silencing, and a wild-type KRAS mutation status. We report here a PMC arising from a Pancreatic Intraductal Papillary Mucinous Neoplasm (IPMN), both having <jats:italic>KRAS<\/jats:italic> and <jats:italic>TP53<\/jats:italic> mutations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 73-year-old woman presenting with right iliac fossa pain. MRI revealed a 16 mm diameter mass in the pancreas, leading to a pancreatic duct stricture and upstream a dilatation of the distal pancreatic duct of Wirsung. A fine needle aspiration was performed, and pathology analysis revealed malignant glandular cells. The patient underwent distal pancreatectomy.<\/jats:p>\n                <jats:p>Gross examination revealed an12 mm indurated white lesion, adjacent to a cystic lesion extending into the rest of the pancreatic body.<\/jats:p>\n                <jats:p>Microscopically, the cystic area represented a mixed (gastric-type and pancreatobiliary-type) IPMN, involving the main and secondary pancreatic ducts with low-grade and high-grade dysplasia. In the periphery of this IPMN, a 14mm associated invasive carcinoma was observed, characterized by focal gland formation and by poorly differentiated cells with a syncytial appearance, associated with a dense lymphoplasmocytic and neutrophilic infiltrate.<\/jats:p>\n                <jats:p>Immunohistochemical analyses showed loss of MSH2 and MSH6 expression. Microsatellite instability was confirmed by molecular test.<\/jats:p>\n                <jats:p>Molecular analysis was performed both on the invasive carcinoma and on the high-grade dysplasia IPMN, revealing the same mutation profile with <jats:italic>KRAS<\/jats:italic> and <jats:italic>TP53<\/jats:italic> mutations.<\/jats:p>\n                <jats:p>The proposed diagnosis was mixed IPMN with associated invasive medullary carcinoma that presented loss of MSH2 and MSH6 expression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present case reports for the first time, at the best of our knowledge, the coexistence of IPMN lesions and PMC, both having the same molecular alterations. It also describes the second case of PMC with microsatellite instability, MSH2 and MSH6 silenced.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13000-021-01178-0","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T03:02:23Z","timestamp":1639364543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pancreatic medullary carcinoma developed on a pancreatic intraductal papillary mucinous neoplasm with loss of MSH2 and MSH6 expression: a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Camille","family":"Verocq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Lucie","family":"Racu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bafort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Butorano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Perez-Casanova Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Navez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Witterwulghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Sheahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall","family":"Swan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Closset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Van Laethem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calliope","family":"Maris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"D\u2019Haene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"1178_CR1","doi-asserted-by":"crossref","unstructured":"L\u00fcttges J, Kl\u00f6ppel G. Update on the Pathology and Genetics of Exocrine Pancreatic Tumors with Ductal Phenotype: Precursor Lesions and New Tumor Entities. Dig Dis. 2001;19.","DOI":"10.1159\/000050649"},{"key":"1178_CR2","doi-asserted-by":"crossref","unstructured":"Kl\u00f6ppel G, L\u00fcttges J. The Pathology of Ductal-type Pancreatic Carcinomas and Pancreatic Intraepithelial Neoplasia: Insights for Clinicians. Curr Gastroenterol Rep. 2004;6.","DOI":"10.1007\/s11894-004-0037-y"},{"key":"1178_CR3","unstructured":"WHO Classification of Tumours Editorial Board. Digestive System Tumours (5th edition). IARC. Vol.\u00a01. Lyon; 2019."},{"key":"1178_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0002-9440(10)64698-6","volume":"156","author":"RE Wilentz","year":"2000","unstructured":"Wilentz RE, Goggins M, Redston M, Marcus VA, Adsay NV, Sohn TA, et al. Genetic, Immunohistochemical, and Clinical Features of Medullary Carcinoma of the Pancreas. Am J Pathol. 2000;156:5.","journal-title":"Am J Pathol"},{"key":"1178_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.humpath.2006.06.024","volume":"37","author":"N Banville","year":"2006","unstructured":"Banville N, Geraghty R, Fox E, Leahy DT, Green A, Keegan D, et al. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Hum Pathol. 2006;37:11.","journal-title":"Hum Pathol"},{"key":"1178_CR6","unstructured":"Union for International Cancer Control UICC. TNM Classification of Malignant Tumours Eight Edition. John Wiley & Sons. UK; 2017. 253 p."},{"key":"1178_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1371\/journal.pone.0138245","volume":"10","author":"N D\u2019Haene","year":"2015","unstructured":"D\u2019Haene N, Le Mercier M, De N\u00e8ve N, Blanchard O, Delaunoy M, El Housni H, et al. Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers. PLoS One. 2015;10:9.","journal-title":"PLoS One"},{"key":"1178_CR8","first-page":"6","volume":"152","author":"M Goggins","year":"1998","unstructured":"Goggins M, Offerhaus GJA, Hilgers W, Grifin CA, Shekher M, Tang D, et al. Pancreatic Adenocarcinomas with DNA Replication Errors (RER+) Are Associated with Wild-Type K-ras and Characteristic Histopathology. Am J Pathol. 1998;152:6.","journal-title":"Am J Pathol"},{"key":"1178_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.21037\/cco.2017.12.01","volume":"6","author":"ME Mostafa","year":"2017","unstructured":"Mostafa ME, Erbarut-Seven I, Pehlivanoglu B, Adsay V. Pathologic classification of \u2018pancreatic cancers\u2019: current concepts and challenges. Chin Clin Oncol. 2017;6:6.","journal-title":"Chin Clin Oncol"},{"key":"1178_CR10","first-page":"6","volume":"103","author":"JD Cumplido-Bur\u00f3n","year":"2011","unstructured":"Cumplido-Bur\u00f3n JD, Toral-Pe\u00f1a JC. Carcinoma medular de p\u00e1ncreas: una entidad relativamente nueva. Rev Esp Enferm Dig (Madrid). 2011;103:6.","journal-title":"Rev Esp Enferm Dig (Madrid)"},{"key":"1178_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pan.2015.03.016","volume":"15","author":"RT Samdani","year":"2015","unstructured":"Samdani RT, Hechtman JF, O\u2019Reilly E, DeMatteo R, Sigel CS. EBV-associated lymphoepithelioma-like carcinoma of the pancreas: case report with targeted sequencing analysis. Pancreatology. 2015;15:3.","journal-title":"Pancreatology"},{"key":"1178_CR12","unstructured":"Yamamoto H, Itoh F, Nakamura H, Sasaki S, Perucho M, Imai K. Genetic and Clinical Features of Human Pancreatic Ductal Adenocarcinomas with Widespread Microsatellite Instability. Cancer Res. 2001;61."},{"key":"1178_CR13","doi-asserted-by":"crossref","unstructured":"Kryklyva V, ter Liden E, Kroeze L, de Voer RM, van der Kolk BM, Stommel MWJ et al.. Medullary Pancreatic Carcinoma Due to Somatic POLE Mutation. A Distinctive Pancreatic Carcinoma With Marked Long-Term Survival. Pancreas. 2020;49:7.","DOI":"10.1097\/MPA.0000000000001588"},{"key":"1178_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ctg.2017.3","volume":"8","author":"KC Patra","year":"2017","unstructured":"Patra KC, Bardeesy N, Mizukami Y. Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm. Clin Transl Gastroenterol. 2017;8:4.","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-021-01178-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-021-01178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T03:03:02Z","timestamp":1639364582000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-021-01178-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1178"],"URL":"https:\/\/doi.org\/10.1186\/s13000-021-01178-0","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patients at admission to Erasme Hospital received the information that the patient\u2019s surplus biological material can be used for research, unless they don\u2019t consent (opt out).The document has been established by the local ethics committee (ethics committee Erasme-ULB) and is in accordance with Belgian and International law (Helsinki declaration).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We don\u2019t have any opt out for the patient (see above).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}